表紙SALE
市場調查報告書
商品編碼
1027926

輸血設備的市場預測、競爭趨勢和增長機會(截至 2026 年):按產品、血液成分、最終用戶和地區

Global Blood Transfusion Devices Market By Product, By Blood Component, By End User, By Region, Competition, Forecast & Opportunities, 2026

出版日期: | 出版商: TechSci Research | 英文 116 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

  • 全貌
  • 簡介
  • 目錄
簡介

在預測期內,全球輸血設備市場預計將以大約 6% 的複合年增長率增長。

預計全球手術數量增加、技術進步和血液相關疾病增加等因素將推動市場增長。

從產品來看,Apheresis Systems 部門預計將在 2020 年佔據最大份額,並在預測期內保持領先地位。這是由於其廣泛用於治療白血病。還用於治療嚴重的類風濕關節炎、系統性紅斑狼瘡、Goodpasture綜合徵、多發性肌炎、皮膚真菌病、先兆子癇和妊娠期先兆子癇,預計未來會越來越多……

本報告探索全球輸血器械市場,定義和概述市場,分析新型冠狀病毒感染(COVID-19)和其他市場影響因素,分析客戶反饋和市場。總結了規模變化/預測,按產品/血液成分/最終用戶細分,按地區/主要國家、競爭環境、市場份額、主要公司簡介等進行詳細分析。

目錄

第 1 章產品概述

第二章調查方法

第 3 章 COVID-19 的影響

第 4 章執行摘要

第五章客戶反饋

第 6 章世界市場展望

  • 市場規模/預測
  • 市場份額/預測
    • 按產品
      • 血液分離系統
      • 輸液器
      • 暖血器
      • 靜脈通路裝置
      • 過濾器
      • 其他
    • 按血液成分
      • 全血
      • 等離子
      • 紅細胞
      • 其他
    • 最終用戶
      • 醫院
      • 門診手術中心
      • 透析中心
      • 血庫
      • 其他
    • 按公司
    • 按地區
  • 產品市場地圖

第七章亞太市場分析/預測

  • 市場規模/預測
  • 市場份額/預測
    • 按產品
    • 按血液成分
    • 最終用戶
    • 按國家/地區

第八章歐洲市場分析與預測

  • 市場規模/預測
  • 市場份額/預測
    • 按產品
    • 按血液成分
    • 最終用戶
    • 按國家/地區

第九章北美市場分析與預測

  • 市場規模/預測
  • 市場份額/預測
    • 按產品
    • 按血液成分
    • 最終用戶
    • 按國家/地區

第10章南美市場分析/預測

  • 市場規模/預測
  • 市場份額/預測
    • 按產品
    • 按血液成分
    • 最終用戶
    • 按國家/地區

第11章中東和非洲市場分析與預測

  • 市場規模/預測
  • 市場份額/預測
    • 按產品
    • 按血液成分
    • 最終用戶
    • 按國家/地區

第 12 章市場動態

  • 促進因素
  • 挑戰

第 13 章市場趨勢

第14章競爭形勢

  • 競爭前景
  • 公司簡介
    • Fresenius Kabi AG
    • Grifols S.A.
    • Terumo Corporation
    • B. Braun Melsungen AG
    • Becton, Dickinson, and Company
    • Immucor Inc.
    • Haemonetics Corporation
    • Kaneka Corporation
    • Macopharma SA
    • Tenko International Group Corp

第15章 策略建議

第16章 關於出版商&免責事項

目錄
Product Code: 5061

Global blood transfusion devices market is expected to grow at a CAGR of around 6% during the forecast period. The global blood transfusion devices market is driven by upsurge in count of surgical procedures being carried out across the globe. Moreover, developments in terms of technology is expected to positively impact the growth of the market during the forecast period. Also, rise in number of blood related disorders is further expected to bolster the growth of market over the next few years.

The global blood transfusion devices market is segmented based on product, type, blood component, end user, company, and region. Based on product, the market can be categorized into apheresis systems, infusion devices, blood warmers, venous access devices, filters, and others. Out of these, the apheresis systems segment dominated the market in terms of largest market share until 2020 and is expected to maintain leading position in the market during the forecast period as well. This can be ascribed to its wide use for the treatment of leukostasis, which is caused by increased white blood count in leukaemia. In addition to this, apheresis system is also used for treating severe rheumatoid arthritis, in order to minimize the risk associated with antibody-mediated rejection of organ during, systemic lupus, goodpasture syndrome, polymyositis or dermatomycosis, and preeclampsia and eclampsia during pregnancy, which is anticipated to boost the growth of the segment over the coming years.

Major players operating in the global blood transfusion devices market include Fresenius Kabi AG, Grifols S.A., Terumo Corporation, B. Braun Melsungen AG, Becton, Dickinson, Company, Immucor Inc., Haemonetics Corporation, Kaneka Corporation, Macopharma SA, Tenko International Group Corp and others. The companies are developing advanced technologies and launching new products to stay competitive in the market. Other competitive strategies include mergers & acquisitions, partnerships, agreements, and new developments.

Years considered for this report:

  • Historical Years: 2016-2019
  • Base Year: 2020
  • Estimated Year: 2021
  • Forecast Period: 2022-2026

Objective of the Study:

  • To analyze and estimate the market size of global blood transfusion devices market from 2016 to 2020.
  • To estimate and forecast the market size of global blood transfusion devices market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast global blood transfusion devices market based on product, blood component, end user, company and regional distribution.
  • To identify dominant region or segment in the global blood transfusion devices market.
  • To identify drivers and challenges for global blood transfusion devices market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global blood transfusion devices market.
  • To conduct pricing analysis for global blood transfusion devices market.
  • To identify and analyze the profile of leading players operating in global blood transfusion devices market.
  • To identify key sustainable strategies adopted by market players in global blood transfusion devices market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers and presence of all major players across the globe.

TechSci Research calculated the market size of global blood transfusion devices market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Blood transfusion devices manufacturers, suppliers and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to blood transfusion devices
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global blood transfusion devices market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Blood Transfusion Devices Market, By Product:

Apheresis Systems

Infusion Devices

Blood Warmers

Venous Access Devices

Filters

Others

  • Global Blood Transfusion Devices Market, By Blood Component:

Whole Blood

Plasma

RBC

Others

  • Global Blood Transfusion Devices Market, By End User:

Hospital

Ambulatory Surgical Centers

Dialysis Centers

Blood Bank

Other

  • Global Blood Transfusion Devices Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global blood transfusion devices market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Blood Transfusion Devices Market

4. Executive Summary

5. Voice of Customer

6. Global Blood Transfusion Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Apheresis Systems, Infusion Devices, Blood Warmers, Venous Access Devices, Filters, Others)
    • 6.2.2. By Blood Component (Whole Blood, Plasma, RBC, Others)
    • 6.2.3. By End User (Hospital, Ambulatory Surgical Centers, Dialysis Centers, Blood Bank, Other)
    • 6.2.4. By Company (2020)
    • 6.2.5. By Region
  • 6.3. Product Market Map

7. Asia-Pacific Blood Transfusion Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Blood Component
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Blood Transfusion Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Blood Component
        • 7.3.1.2.3. By End User
    • 7.3.2. India Blood Transfusion Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Blood Component
        • 7.3.2.2.3. By End User
    • 7.3.3. Australia Blood Transfusion Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Blood Component
        • 7.3.3.2.3. By End User
    • 7.3.4. Japan Blood Transfusion Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Blood Component
        • 7.3.4.2.3. By End User
    • 7.3.5. South Korea Blood Transfusion Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Blood Component
        • 7.3.5.2.3. By End User

8. Europe Blood Transfusion Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Blood Component
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Blood Transfusion Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Blood Component
        • 8.3.1.2.3. By End User
    • 8.3.2. Germany Blood Transfusion Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Blood Component
        • 8.3.2.2.3. By End User
    • 8.3.3. United Kingdom Blood Transfusion Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Blood Component
        • 8.3.3.2.3. By End User
    • 8.3.4. Italy Blood Transfusion Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Blood Component
        • 8.3.4.2.3. By End User
    • 8.3.5. Spain Blood Transfusion Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Blood Component
        • 8.3.5.2.3. By End User

9. North America Blood Transfusion Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Blood Component
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Blood Transfusion Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Blood Component
        • 9.3.1.2.3. By End User
    • 9.3.2. Mexico Blood Transfusion Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Blood Component
        • 9.3.2.2.3. By End User
    • 9.3.3. Canada Blood Transfusion Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Blood Component
        • 9.3.3.2.3. By End User

10. South America Blood Transfusion Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Blood Component
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Blood Transfusion Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Blood Component
        • 10.3.1.2.3. By End User
    • 10.3.2. Argentina Blood Transfusion Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Blood Component
        • 10.3.2.2.3. By End User
    • 10.3.3. Colombia Blood Transfusion Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Blood Component
        • 10.3.3.2.3. By End User

11. Middle East and Africa Blood Transfusion Devices Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product
    • 11.2.2. By Blood Component
    • 11.2.3. By End User
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Blood Transfusion Devices Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product
        • 11.3.1.2.2. By Blood Component
        • 11.3.1.2.3. By End User
    • 11.3.2. Saudi Arabia Blood Transfusion Devices Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product
        • 11.3.2.2.2. By Blood Component
        • 11.3.2.2.3. By End User
    • 11.3.3. UAE Blood Transfusion Devices Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product
        • 11.3.3.2.2. By Blood Component
        • 11.3.3.2.3. By End User
    • 11.3.4. Kuwait Blood Transfusion Devices Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Product
        • 11.3.4.2.2. By Blood Component
        • 11.3.4.2.3. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Company Profiles (SWOT Analysis of Top 5 Players Profiled)
    • 14.2.1. Fresenius Kabi AG
    • 14.2.2. Grifols S.A.
    • 14.2.3. Terumo Corporation
    • 14.2.4. B. Braun Melsungen AG
    • 14.2.5. Becton, Dickinson, and Company
    • 14.2.6. Immucor Inc.
    • 14.2.7. Haemonetics Corporation
    • 14.2.8. Kaneka Corporation
    • 14.2.9. Macopharma SA
    • 14.2.10. Tenko International Group Corp

15. Strategic Recommendations

16. About Us & Disclaimer